These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 527789

  • 1. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C, Descos L, André F, Vignal J, Druguet M.
    Gastroenterol Clin Biol; 1979 Nov; 3(11):789-94. PubMed ID: 527789
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 4. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D, Pawlica D, Ciećko-Michalska I, Solnica B, Mach T.
    Przegl Lek; 2010 Jan; 67(2):114-8. PubMed ID: 20557011
    [Abstract] [Full Text] [Related]

  • 5. Indices of granulocyte activity in ulcerative colitis and Crohn's disease.
    Koldkjaer O, Klitgaard NA, Schmidt KG.
    Dan Med Bull; 1977 Apr; 24(2):72-6. PubMed ID: 852316
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B, Krznarić Z, Sentić M, Milicić D, Korać B, Cvorisćec D, Stavljenić A.
    Lijec Vjesn; 1990 Apr; 112(9-10):281-4. PubMed ID: 2093781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Differential diagnosis of ulcerative colitis and Crohn's disease (author's transl)].
    Morson BC.
    Przegl Lek; 1981 Apr; 38(6):491-8. PubMed ID: 7268049
    [No Abstract] [Full Text] [Related]

  • 11. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S, Florén CH, Lindhagen T, Starck M, Stewenius J, Nässberger L.
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Marginal area between ulcerative colitis and Crohn's disease].
    Mussche M, Elewaut A, Barbier F.
    Tijdschr Gastroenterol; 1971 Jun; 14(4):258-71. PubMed ID: 5160650
    [No Abstract] [Full Text] [Related]

  • 16. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).
    Meucci G, Bortoli A, Riccioli FA, Girelli CM, Radaelli F, Rivolta R, Tatarella M.
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):909-13. PubMed ID: 10514127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
    Lecis P, Germanà B, Papa N, Bertiato G, Doglioni C, Galliani E, Biedo FC.
    Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.